Tower Research Capital (TRC)’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $9.6K | Sell |
|
|||||
|
2025
Q3 | $15.4K | Sell |
|
|||||
|
2025
Q2 | $30.6K | Sell |
|
|||||
|
2025
Q1 | $64.1K | Buy |
|
|||||
|
2024
Q4 | $12.1K | Sell |
|
|||||
|
2024
Q3 | $39.3K | Buy |
|
|||||
|
2024
Q2 | $31.4K | Buy |
|
|||||
|
2024
Q1 | $5.94K | Sell |
|
|||||
|
2023
Q4 | $92.5K | Buy |
|
|||||
|
2023
Q3 | $39.9K | Buy |
|
|||||
|
2023
Q2 | $21.5K | Buy |
|
|||||
|
2023
Q1 | $11K | Sell |
|
|||||
|
2022
Q4 | $101K | Buy |
|
|||||
|
2022
Q3 | $102K | Sell |
|
|||||
|
2022
Q2 | $167K | Buy |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q4 | $11K | Sell |
|
|||||
|
2021
Q3 | $231K | Buy |
|
|||||
|
2021
Q2 | $36K | Buy |
|
|||||
|
2021
Q1 | $45K | Buy |
|
|||||
|
2020
Q4 | $14K | Buy |
|